Regional Conference Tampa

Tampa, FL | August 14-15, 2018

Tampa Convention Center

SAFE Opioid Prescribing: Part 3

Description

During this session you will learn about ER/LA Opioids - Goals of Therapy, Monitoring and Patient Education of ER/LA Opioids, Assessing ER/LA Opioid Products: Similarities and Differences Prescribers Need to Know. This educational activity is supported by an independent educational grant from the Extended-Release/Long-Acting Opioid Analgesic REMS Program Companies. Please see http://ce.er-la-opioidrems.com/IwgCEUI/rems/pdf/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Extended-Release/Long-Acting Opioid Analgesics REMS education requirements issued by the US Food & Drug Administration.

Learning Objectives

Implement patient assessment strategies, including tools to assess risk of abuse, misuse, or addiction when prescribing extended-release (ER/LA) opioids

Employ approaches to safely initiate therapy, modify dose, and discontinue ER/LA opioids

Monitor patients by evaluating treatment goals and implementing periodic urine drug testing (UDT)

Employ patient education strategies about the safe use of ER/LA opioids

Identify similarities and differences among ER/LA opioids


Syllabus

Download a PDF of the Presented Slides.

DOWNLOAD

Speakers

Charles E. Argoff, MD, FABPM

Dr Argoff is Professor of Neurology at Albany Medical College and Director of the Comprehensive Pain Center at Albany Medical Center in New York. He is a member of the American Academy of Neurology, the International Association for the Study of Pain...

View Full Bio

Katherine E. Galluzzi, DO, CMD, FACOFP

Dr. Galluzzi is professor and chair of the Department of Geriatrics and director of Comprehensive Care at the Philadelphia College of Osteopathic Medicine in Pennsylvania. Dr. Galluzzi received her medical degree from the West Virginia School of Oste...

View Full Bio